Pfizer Inc. et al v. Natco Pharma Ltd.

1:24-cv-00625 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Colm F. Connolly
Filed May 23, 2024
Case Flags ANDA and PATENT
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand None
Lead Case 1:24-cv-00621
Last Updated: 5 months, 2 weeks ago Show Interactive Timeline
Upcoming Events
5 Months
  • 9/5/2025
Joint Claim Construction Brief due by 9/5/2025.
Source
Add
6 Months
  • 9/26/2025
Amended Pleadings due by 9/26/2025.
Joinder of Parties due by 9/26/2025.
Source
Add
7 Months
  • 10/22/2025
A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly.
Source
Add
12 Months
  • 3/25/2026
Fact Discovery completed by 3/25/2026.
Source
Add
18 Months
  • 9/24/2026
Expert Discovery due by 9/24/2026.
Source
Add
Filing Date # Docket Text
9/30/2024Case associated with lead case: Create association to 1:24-cv-00621-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 24-621-CFC ONLY. (nmf) (Entered: 09/30/2024)
9/30/2024SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all future filings shall be made in Lead Case No. 24-621-CFC ONLY. Joinder of Parties due by 9/26/2025. Amended Pleadings due by 9/26/2025. Fact Discovery completed by 3/25/2026. Expert Discovery due by 9/24/2026. Joint Claim Construction Brief due by 9/5/2025. A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/15/2027. A Final Pretrial Conference is set for 2/8/2027 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/16/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 09/30/2024)
9/30/2024
  • Motionby Π
PROPOSED ORDER --[Proposed] Scheduling Order-- by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Pfizer Ireland Pharmaceutials. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 09/30/2024)
8/28/2024
  • Motion to Dismiss (Demurrer)Granted
SO ORDERED, re 20 STIPULATION and Order Dismissing Defendant Natco Pharma, Inc. and Amending Caption to Reflect Same. Natco Pharma, Inc. terminated. Signed by Judge Colm F. Connolly on 8/28/2024. (nmf) (Entered: 08/28/2024)
8/27/2024 STIPULATION and Proposed Order Dismissing Defendant Natco Pharma, Inc. and Amending Caption to Reflect Same by Natco Pharma Ltd., Natco Pharma, Inc.. (Farnan, Kelly) (Entered: 08/27/2024)
8/12/2024
  • Order
Order Setting In-Person Scheduling Conference: A Scheduling Conference is set for 10/2/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 8/12/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 08/12/2024)
8/8/2024Pro Hac Vice Attorney Christopher J. Sorenson, Andrew O. Larsen, Jason M. Wiener for Natco Pharma Ltd. and Natco Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) (Entered: 08/08/2024)
8/8/2024
  • Answerby Δ
ANSWER to 1 Complaint, by Natco Pharma Ltd., Natco Pharma, Inc..(Farnan, Kelly) (Entered: 08/08/2024)
8/8/2024 Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding response to the Court's July 8, 2024 Order - re (20 in 1:24-cv-00621-CFC, 20 in 1:24-cv-00621-CFC, 12 in 1:24-cv-00625-CFC, 12 in 1:24-cv-00625-CFC, 13 in 1:24-cv-00626-CFC, 13 in 1:24-cv-00626-CFC, 12 in 1:24-cv-00623-CFC, 12 in 1:24-cv-00623-CFC, 13 in 1:24-cv-00627-CFC, 13 in 1:24-cv-00627-CFC, 12 in 1:24-cv-00624-CFC, 12 in 1:24-cv-00624-CFC, 13 in 1:24-cv-00622-CFC, 13 in 1:24-cv-00622-CFC) Order,, Set Deadlines,. (Dellinger, Megan) (Entered: 08/08/2024)
7/31/2024
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, Andrew O. Larsen, Jason M. Wiener and W. Reid Morris filed by Natco Pharma Ltd., Natco Pharma, Inc. Signed by Judge Colm F. Connolly on 7/31/2024. (nmf) (Entered: 07/31/2024)
7/31/2024 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Natco Pharma Inc. for Natco Pharma Ltd. filed by Natco Pharma Ltd., Natco Pharma, Inc.. (Farnan, Kelly) (Entered: 07/31/2024)
7/31/202415Pro Hac Vice Fee - Credit Card Payment received for Christopher J. Sorenson, Andrew O. Larsen, Jason M. Wiener, and W. Reid Morris. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, Andrew O. Larsen, Jason M. Wiener and W. Reid Morris )( Payment of $ 200, receipt number ADEDC-4464911).(Farnan, Kelly) (Entered: 07/31/2024)
7/31/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, Andrew O. Larsen, Jason M. Wiener and W. Reid Morris - filed by Natco Pharma Ltd., Natco Pharma, Inc.. (Farnan, Kelly) (Entered: 07/31/2024)
7/25/2024
  • Motion to Extend Time
SO ORDERED, re 13 STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including August 12, 2024, filed by Natco Pharma Ltd., Natco Pharma, Inc. Reset Answer Deadlines: Natco Pharma Ltd. answer due 8/12/2024; Natco Pharma, Inc. answer due 8/12/2024. Ordered by Judge Colm F. Connolly on 7/25/2024. (kmd) (Entered: 07/25/2024)
7/25/2024
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME for Defendants to Answer the Complaint to through and including August 12, 2024 - filed by Natco Pharma Ltd., Natco Pharma, Inc.. (Farnan, Kelly) (Entered: 07/25/2024)
7/8/2024
  • Order
ORDER: on or before August 9, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/ or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER Setting Deadlines: ( Notice of Compliance deadline set for 8/9/2024.) Signed by Judge Colm F. Connolly on 7/8/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 07/08/2024)
5/31/2024Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc.,and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/31/2024Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc.,Dimitrios T. Drivas for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/31/2024Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024)
5/30/2024
  • Order
SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd) (Entered: 05/30/2024)
5/30/202411Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419019).(Dellinger, Megan) (Entered: 05/30/2024)
5/30/2024
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard - filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Dellinger, Megan) (Entered: 05/30/2024)
5/29/2024WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Natco Pharma, Inc. waiver sent on 5/29/2024, answer due 7/29/2024. (Dellinger, Megan) (Entered: 05/29/2024)
5/29/2024WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Natco Pharma Ltd. waiver sent on 5/29/2024, answer due 7/29/2024. (Dellinger, Megan) (Entered: 05/29/2024)
5/29/2024
  • Standing Order
STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 05/29/2024)
5/29/2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb) (Entered: 05/29/2024)
5/23/2024Summons Issued as to Natco Pharma Ltd. on 5/23/2024; Natco Pharma, Inc. on 5/23/2024. (Attachments: # 1 Summons Issued)(oam) (Entered: 05/24/2024)
5/23/2024 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Pfizer Inc. for Pfizer Ireland Pharmaceuticals filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals. (oam) (Entered: 05/24/2024)
5/23/2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,083,724 B2. (oam) (Entered: 05/24/2024)
5/23/2024 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 19, 2024. Date of Expiration of Patent: March 25, 2039.Thirty Month Stay Deadline: 8/27/2027. (oam) (Entered: 05/24/2024)
5/23/2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 05/24/2024)
5/23/2024
  • Complaint
COMPLAINT filed for PATENT INFRINGEMENT against Natco Pharma Ltd., Natco Pharma, Inc. ( Filing fee $ 405, receipt number ADEDC-4414652.) - filed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 05/24/2024)